Frances Xu

Herbert Smith Freehills (Shanghai)
Lawyer (Partner)

Frances is a Partner at the Joint Operation firm Kewei in Shanghai. She advises on competition law issues across a broad range of industries, including pharmaceuticals, TMT, automotive, luxury products, energy, essential facilities and public utilities.

Linked author

Herbert Smith Freehills (Shanghai)

Articles

843 Bulletin

Adelaide Luke, Frances Xu, Howard Chan, Hazel Xu The Chinese State Administration for Market Regulation launches public consultations on its proposed amendments to administrative sanctions for price-related illegal activities with special focus on the digital sector

179

The State Administration for Market Regulation (SAMR), China’s primary competition enforcement regulator, recently published a consultation draft of its amendments to the existing Provisions on Administrative Sanctions Against Price-related Illegal Activities on 2 July 2021 (the Provisions). The (...)

Adelaide Luke, Howard Chan, Frances Xu The Chinese State Administration for Market Regulation fines internet companies for failures to notify past transactions (Alibaba / China Literature / Shenzhen)

112

On 14 December 2020, China’s State Administration for Market Regulation (SAMR) imposed fines against three internet based companies Alibaba Investment Limited, China Literature Limited and Shenzhen Hive-box Network Technology for respective failures to notify past transactions under the merger (...)

Frances Xu, Adelaide Luke, Frederick Good The Chinese SAMR fines 3 pharmaceutical companies for abuse of dominance in the distribution of an injectable drug and confirms that pharmaceuticals and medical devices sectors continue to be an enforcement priority amid the COVID-19 outbreak (Kanghui / Puyunhui / Taiyangshen)

462

On 9 April 2020, China’s State Administration for Market Regulation (SAMR) fined 3 pharmaceutical companies for abuse of dominance in the distribution of injectable calcium gluconate Active Pharmaceutical Ingredient (API). The three companies were found to be in breach of the PRC’s Anti-Monopoly (...)

Send a message